BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Regulus Therapeutics, Inc. Presents Positive Preclinical Data On miR-21 And miR-221 Oncology Programs In Oral And Poster Presentations At American Association for Cancer Research 2014 Annual Meeting 4/7/2014 7:20:45 AM    More...
Regulus Therapeutics, Inc. To Present At The 13th Annual Needham Healthcare Conference 4/7/2014 6:32:27 AM    More...
Regulus Therapeutics, Inc. Commences Dosing RG-101 In Healthy Volunteers In Phase I Study 3/5/2014 10:39:10 AM    More...
Regulus Therapeutics, Inc. Provides Strategic Update And Reports Fourth Quarter And Year-End 2013 Financial Results And Recent Highlights 2/28/2014 6:14:46 AM    More...
Regulus Therapeutics, Inc. To Present At Cowen and Company 34th Annual Healthcare Conference 2/27/2014 6:26:50 AM    More...
Regulus Therapeutics, Inc. Announces Timing For Fourth Quarter And Year-End 2013 Financial Results Webcast And Conference Call 2/21/2014 6:21:45 AM    More...
Regulus Therapeutics, Inc. Advances Orphan Disease Portfolio With Nomination Of RG-012 As Clinical Development Candidate For The Treatment Of Alport Syndrome 2/19/2014 10:21:16 AM    More...
Regulus Therapeutics, Inc. Appoints Head Of Regulus MicroMarkers™ R&D Division 2/13/2014 11:26:13 AM    More...
Regulus Therapeutics, Inc. Renews Strategic Alliance With Sanofi (France) (SAN.PA) To Focus On Orphan Disease And Oncology Targets And Receives Additional $10 Million Equity Investment 2/5/2014 6:30:02 AM    More...
Regulus Therapeutics, Inc. Strengthens Executive Management Team With Addition Of David Szekeres As Chief Business Officer And General Counsel 2/4/2014 7:13:18 AM    More...
12345678910...